K 777

Drug Profile

K 777

Alternative Names: APC-3316; CRA-3316; K-777

Latest Information Update: 28 Jul 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Celera Genomics Group; University of California at San Francisco
  • Developer Institute for OneWorld Health; National Institutes of Health (USA)
  • Class Amides; Antiprotozoals; Piperazines; Small molecules; Sulfones
  • Mechanism of Action Cruzain inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Chagas disease

Most Recent Events

  • 03 Sep 2005 This compound is still in active development
  • 27 Feb 2002 Preclinical trials in Chagas' disease in USA (PO,Tablet)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top